Financials data is unavailable for this security.
View more
Year on year Worldwide Healthcare grew revenues -- from -135.35m to 16.03m while net income improved from a loss of 141.53m to a smaller loss of 8.79m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -4.14% |
---|---|
Return on equity | -4.47% |
Return on investment | -4.47% |
More ▼
Growth rates in GBP
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 16.98% and 93.71%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Biotechnology & Drugs industry pay a dividend. Additionally, five year annualized dividend per share growth ranks above the industry average relative to its peers.
Div yield(5 year avg) | 0.85% |
---|---|
Div growth rate (5 year) | 12.12% |
Payout ratio (TTM) | -- |
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | -18.41 |
More ▼